ArticleCancer immunology, immunotherapy : CII2011

In vivo activity of novel anti-ErbB2 antibody chA21 alone and with Paclitaxel or Trastuzumab in breast and ovarian cancer xenograft models.

Guodong Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.